Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements
Obstetrics & Gynecology Science · 2026-07-15 · 69 (4) · 303-304
DOI: 10.5468/ogs.26134 ↗At a glance
Journal article in Obstetrics & Gynecology Science, published on 2026-07-15. Written by Siyuan Zhu. Institution: Department of Gynecology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. 858462770@qq.com. 4 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Department of Gynecology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. 858462770@qq.com.
Cite
APA
Zhu, S. (2026). Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements. Obstetrics & Gynecology Science, 69(4), 303-304. https://doi.org/10.5468/ogs.26134
Vancouver
Zhu S. Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements. Obstetrics & Gynecology Science. 2026;69(4):303-304. doi:10.5468/ogs.26134
BibTeX
@article{Zhu2026,
author = {Zhu, Siyuan},
title = {Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements},
journal = {Obstetrics & Gynecology Science},
year = {2026},
volume = {69},
number = {4},
pages = {303--304},
doi = {10.5468/ogs.26134}
}
EUVIMED